Plant-based Biologics Market , by Plant Parts (Seeds-based, Leaf-based, Tubers-based, Fruits-based, Others), by Source (Tobacco, Carrot, Alfalfa, Moss, Rice, Duckweed, Others), Regional Analysis (North America, Europe, Asia Pacific, LAMEA): Global Opportunity Analysis and Industry Forecast, 2019–2026
- RES4072119
- 180 Pages
- March 2020
- Healthcare
Plant-based biologics are also called as plant-derived biologics and can be defined as a Schedule D drug which is produced by using plant molecular farming. Plants offer several key advantages like high scalability and they are potentially lower in cost. So various plants such as tobacco, carrot, and others are highly used for the production of biologics.
Enormously rising demand for biologics mainly due to growth in the prevalence of chronic diseases like Alzheimer's disease, diabetes, and heart disease, has augmented the plant-based biologics market, during the forecast period. Utilization of plants for the manufacturing of biologics minimizes contamination from adventitious agents, which is one of the significant factors for the growth of plant-based biologics market. Furthermore, plant-based biologics provide multiple advantages like they are low in cost and they have the capability to manufacture complex and novel molecules. Alternatives like mammalian biopharmaceuticals are projected to decline the plant-based biologics market growth, over the forecast period. In recent years, the novel transient expression vectors are produced which are highly advanced than traditional plant-made biologics. These biologics have the ability to produce therapeutics and advanced vaccines to control bioterrorism or pandemics. In addition, these plant-derived biologics have key features such as they are cost-effective, and they have high scalability. These above-mentioned elements are projected to create vast opportunities for plant-based biologics market.
Based on the plant parts, the global plant-based biologics is broadly categorized into seed-based, leaf-based, tuber-based, fruit-based, and others. Leaf-based biologics have the largest market share and it is anticipated to register a revenue of $71.0 million by 2026, increasing from $46.0 million in 2018.
Based on source, global plant-based biologics are broadly categorized into tobacco, carrot, alfalfa, moss, rice, duckweed, and others. Plant-based Biologics market of the Duckweed segment shall have extensive growth and it is projected to generate a revenue of $12.0 million by 2026,rising from $5.0 million in 2018. Tobacco based biologics segment has a significant share in the market and is expected to register a revenue of $71.0 million, by 2026, throughout the forecast period.
Plant-based biologics market in Europe is the fastest-growing and it is projected to grow at a healthy CAGR of 8.1% by registering revenue of $51.5 million by 2026. The North America plant-based biologics market registered a revenue of $54.1 million in 2018 and it is projected to generate revenue of $87.3 million during the projected period.
Some of the major Plant-based Biologics market players include Ventria Bioscience Inc., Medicago, Inc., iBio, Icon Genetics GmbH, PhycoBiologics Inc., Fraunhofer IME, PlantForm, Kentucky BioProcessing, Inc., Mapp Biopharmaceautical - Leaf Bio., and Greenovation Biotech GmbH. Plant-based biologics market leading players are focusing more on advancements of technology, merger & acquisition and integrated product development. These are the multiple strategies followed by established ventures.
1.1 Desk Research
1.2 Real time insights and validation
1.3 Forecast model
1.4 Assumptions and forecast parameters
1.4.1 Assumptions
1.4.2 Forecast parameters
1.5 Data sources
1.5.1 Primary
1.5.2 Secondary
2 Executive Summary
2.1 360° summary
2.2 Plant Parts trends
2.3 Source trends
3 Market overview
3.1 Market segmentation & definitions
3.2 Key takeaways
3.2.1 Top investment pockets
3.2.2 Top winning strategies
3.3 Porter’s five forces analysis
3.3.1 Bargaining power of consumers
3.3.2 Bargaining power of suppliers
3.3.3 Threat of new entrants
3.3.4 Threat of substitutes
3.3.5 Competitive rivalry in the market
3.4 Market dynamics
3.4.1 Drivers
3.4.2 Restraints
3.4.3 Opportunities
3.5 Technology landscape
3.6 Regulatory landscape
3.7 Patent landscape
3.8 Pricing overview
3.8.1 By Plant Parts
3.8.2 By Source
3.9 Market value chain analysis
3.9.1 Stress point analysis
3.9.2 Raw material analysis
3.9.3 Manufacturing process
3.9.4 Distribution channel analysis
3.9.5 Operating vendors
3.9.5.1 Raw material suppliers
3.9.5.2 Product manufacturers
3.9.5.3 Product distributors
3.10 Strategic overview
4 Plant-based Biologics Market, by Plant Parts
4.1 Seeds-based
4.1.1 Market size and forecast, by region, 2018-2026
4.1.2 Comparative market share analysis, 2018 & 2026
4.2 Leaf-based
4.2.1 Market size and forecast, by region, 2018-2026
4.2.2 Comparative market share analysis, 2018 & 2026
4.3 Tubers-based
4.3.1 Market size and forecast, by region, 2018-2026
4.3.2 Comparative market share analysis, 2018 & 2026
4.4 Fruits-based
4.4.1 Market size and forecast, by region, 2018-2026
4.4.2 Comparative market share analysis, 2018 & 2026
4.5 Others
4.5.1 Market size and forecast, by region, 2018-2026
4.5.2 Comparative market share analysis, 2018 & 2026
5 Plant-based Biologics Market, by Source
5.1 Tobacco
5.1.1 Market size and forecast, by region, 2018-2026
5.1.2 Comparative market share analysis, 2018 & 2026
5.2 Carrot
5.2.1 Market size and forecast, by region, 2018-2026
5.2.2 Comparative market share analysis, 2018 & 2026
5.3 Alfalfa
5.3.1 Market size and forecast, by region, 2018-2026
5.3.2 Comparative market share analysis, 2018 & 2026
5.4 Moss
5.4.1 Market size and forecast, by region, 2018-2026
5.4.2 Comparative market share analysis, 2018 & 2026
5.5 Rice
5.5.1 Market size and forecast, by region, 2018-2026
5.5.2 Comparative market share analysis, 2018 & 2026
5.6 Duckweed
5.6.1 Market size and forecast, by region, 2018-2026
5.6.2 Comparative market share analysis, 2018 & 2026
5.7 Others
5.7.1 Market size and forecast, by region, 2018-2026
5.7.2 Comparative market share analysis, 2018 & 2026
6 Plant-based Biologics Market, by region
6.1 North America
6.1.1 Market size and forecast, by plant parts, 2018-2026
6.1.2 Market size and forecast, by source, 2018-2026
6.1.3 Market size and forecast, by country, 2018-2026
6.1.4 Comparative market share analysis, 2018 & 2026
6.1.5 U.S.
6.1.5.1 Market size and forecast, by plant parts, 2018-2026
6.1.5.2 Market size and forecast, by source, 2018-2026
6.1.5.3 Comparative market share analysis, 2018 & 2026
6.1.6 Canada
6.1.6.1 Market size and forecast, by plant parts, 2018-2026
6.1.6.2 Market size and forecast, by source, 2018-2026
6.1.6.3 Comparative market share analysis, 2018 & 2026
6.1.7 Mexico
6.1.7.1 Market size and forecast, by plant parts, 2018-2026
6.1.7.2 Market size and forecast, by source, 2018-2026
6.1.7.3 Comparative market share analysis, 2018 & 2026
6.2 Europe
6.2.1 Market size and forecast, by plant parts, 2018-2026
6.2.2 Market size and forecast, by source, 2018-2026
6.2.3 Market size and forecast, by country, 2018-2026
6.2.4 Comparative market share analysis, 2018 & 2026
6.2.5 Germany
6.2.5.1 Market size and forecast, by plant parts, 2018-2026
6.2.5.2 Market size and forecast, by source, 2018-2026
6.2.5.3 Comparative market share analysis, 2018 & 2026
6.2.6 UK
6.2.6.1 Market size and forecast, by plant parts, 2018-2026
6.2.6.2 Market size and forecast, by source, 2018-2026
6.2.6.3 Comparative market share analysis, 2018 & 2026
6.2.7 France
6.2.7.1 Market size and forecast, by plant parts, 2018-2026
6.2.7.2 Market size and forecast, by source, 2018-2026
6.2.7.3 Comparative market share analysis, 2018 & 2026
6.2.8 Spain
6.2.8.1 Market size and forecast, by plant parts, 2018-2026
6.2.8.2 Market size and forecast, by source, 2018-2026
6.2.8.3 Comparative market share analysis, 2018 & 2026
6.2.9 Italy
6.2.9.1 Market size and forecast, by plant parts, 2018-2026
6.2.9.2 Market size and forecast, by source, 2018-2026
6.2.9.3 Comparative market share analysis, 2018 & 2026
6.2.10 Rest of Europe
6.2.10.1 Market size and forecast, by plant parts, 2018-2026
6.2.10.2 Market size and forecast, by source, 2018-2026
6.2.10.3 Comparative market share analysis, 2018 & 2026
6.3 Asia Pacific
6.3.1 Market size and forecast, by plant parts, 2018-2026
6.3.2 Market size and forecast, by source, 2018-2026
6.3.3 Market size and forecast, by country, 2018-2026
6.3.4 Comparative market share analysis, 2018 & 2026
6.3.5 China
6.3.5.1 Market size and forecast, by plant parts, 2018-2026
6.3.5.2 Market size and forecast, by source, 2018-2026
6.3.5.3 Comparative market share analysis, 2018 & 2026
6.3.6 India
6.3.6.1 Market size and forecast, by plant parts, 2018-2026
6.3.6.2 Market size and forecast, by source, 2018-2026
6.3.6.3 Comparative market share analysis, 2018 & 2026
6.3.7 Australia
6.3.7.1 Market size and forecast, by plant parts, 2018-2026
6.3.7.2 Market size and forecast, by source, 2018-2026
6.3.7.3 Comparative market share analysis, 2018 & 2026
6.3.8 Rest of Asia Pacific
6.3.8.1 Market size and forecast, by plant parts, 2018-2026
6.3.8.2 Market size and forecast, by source, 2018-2026
6.3.8.3 Comparative market share analysis, 2018 & 2026
6.4 LAMEA
6.4.1 Market size and forecast, by plant parts, 2018-2026
6.4.2 Market size and forecast, by source, 2018-2026
6.4.3 Market size and forecast, by country, 2018-2026
6.4.4 Comparative market share analysis, 2018 & 2026
6.4.5 Latin America
6.4.5.1 Market size and forecast, by plant parts, 2018-2026
6.4.5.2 Market size and forecast, by source, 2018-2026
6.4.5.3 Comparative market share analysis, 2018 & 2026
6.4.6 Middle East
6.4.6.1 Market size and forecast, by plant parts, 2018-2026
6.4.6.2 Market size and forecast, by source, 2018-2026
6.4.6.3 Comparative market share analysis, 2018 & 2026
6.4.7 Africa
6.4.7.1 Market size and forecast, by plant parts, 2018-2026
6.4.7.2 Market size and forecast, by source, 2018-2026
6.4.7.3 Comparative market share analysis, 2018 & 2026
7 Company profiles
7.1 Icon Genetics GmbH
7.1.1 Business overview
7.1.2 Financial performance
7.1.3 Product portfolio
7.1.4 Recent strategic moves & developments
7.1.5 SWOT analysis
7.2 Kentucky BioProcessing, Inc.
7.2.1 Business overview
7.2.2 Financial performance
7.2.3 Product portfolio
7.2.4 Recent strategic moves & developments
7.2.5 SWOT analysis
7.3 Medicago, Inc.
7.3.1 Business overview
7.3.2 Financial performance
7.3.3 Product portfolio
7.3.4 Recent strategic moves & developments
7.3.5 SWOT analysis
7.4 MappBiopharmaceautical - Leaf Bio.
7.4.1 Business overview
7.4.2 Financial performance
7.4.3 Product portfolio
7.4.4 Recent strategic moves & developments
7.4.5 SWOT analysis
7.5 iBio
7.5.1 Business overview
7.5.2 Financial performance
7.5.3 Product portfolio
7.5.4 Recent strategic moves & developments
7.5.5 SWOT analysis
7.6 PlantForm
7.6.1 Business overview
7.6.2 Financial performance
7.6.3 Product portfolio
7.6.4 Recent strategic moves & developments
7.6.5 SWOT analysis
7.7 Greenovation Biotech GmbH
7.7.1 Business overview
7.7.2 Financial performance
7.7.3 Product portfolio
7.7.4 Recent strategic moves & developments
7.7.5 SWOT analysis
7.8 PhycoBiologics Inc.
7.8.1 Business overview
7.8.2 Financial performance
7.8.3 Product portfolio
7.8.4 Recent strategic moves & developments
7.8.5 SWOT analysis
7.9 Ventria Bioscience Inc.
7.9.1 Business overview
7.9.2 Financial performance
7.9.3 Product portfolio
7.9.4 Recent strategic moves & developments
7.9.5 SWOT analysis
7.10 Fraunhofer IME
7.10.1 Business overview
7.10.2 Financial performance
7.10.3 Product portfolio
7.10.4 Recent strategic moves & developments
7.10.5 SWOT analysis
Similar Reports
The global digital pathology market was valued at $3,323 million in 2016, and is expected to reach $8,668 million by 2023, registering a CAGR of 14.8% during the forecast period. Digital pathology is defined as an image-based information setting enabled b...
- Publish Date: February 26, 2018
- $5370
The global regenerative medicine market was valued at $5,444 million in 2016, and is estimated to reach $39,325 million by 2023, registering a CAGR of 32.2% from 2017 to 2023. Regenerative medicines are used to repair, replace, and regenerate tissues & organs that are affected owin...
- Publish Date: May 29, 2018
- $5370
The medical robotics and computer-assisted surgery is a combination of equipment, accessories, software, and services that aid in performing different functions, such as robotic minimally invasive and non-invasive radiosurgeries, rehabilitation therapies, and hospital & pharmacy automation. Surgical robotics...
- Publish Date: May 1, 2016
- $5370
